ArticleJournal of experimental & clinical cancer research : CR2021

Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma.

Cinzia Lanzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.